Abstracts tagged "Early Rheumatoid Arthritis and diagnosis"

Abstract Number: 2025 • 2014 ACR/ARHP Annual Meeting
Factors Associated with Time to Diagnosis from Symptom Onset in Early Rheumatoid Arthritis Patients
Yoon-Kyoung Sung^1,2, Soo-Kyung Cho^2,3, Dam Kim³, Soyoung Won³, Jiyoung Lee³, Jung-Yoon Choe⁴, Chan-Bum Choi^1,2, Seung-Jae Hong⁵, Jae-Bum Jun², Tae-Hwan Kim⁶, Eunmi Koh⁷, Hye-Soon Lee⁸, Jisoo Lee⁹, Dae-Hyun Yoo¹, Bo Young Yoon¹⁰ and Sang-Cheol Bae^1,3, ¹Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ²Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Clinical Research Center for Rheumatoid Arthritis (CRCRA), Seoul, South Korea, ⁴Division of Rheumatology, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁵Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, ⁶Division of Rheumatology, Department of Internal Medicine, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ⁷Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, ⁸Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, ⁹Ewha Womans University School of Medicine, Seoul, South Korea, ¹⁰Inje University Ilsan Paik Hospital, Goyang, South Korea
Background/Purpose Early diagnosis and treatment is an optimal target for better outcomes in rheumatoid arthritis (RA) in clinical practice. To make an early diagnosis, it…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].